Books about Prognosis from Amazon.com

Written by acknowledged leaders in the field, this book is for all neurologist, psychiatrist, and rehabilitationist working with TBI patients This book provides a comprehensive and unique neuromedical view of care for the person with brain injury. The focus is on assesment and treatment of a variety of problems confronting TBI patients during the post-acute period and later. Chapters cover important topics such as epidemiology, preventions, legal issues, life care planning and much more..
Price: $168.00 [Notify me when price goes down.]

Third Edition brings the text up to date with new material and updated references.

• New content includes an introduction to left and interval censored data; the log-logistic distribution; estimation procedures for left and interval censored data; parametric methods iwth covariates; Cox's proportional hazards model (including stratification and time-dependent covariates); and multiple responses to the logistic regression model.
• Coverage of graphical methods has been deleted.
• Large data sets are provided on an FTP site for readers' convenience.
• Bibliographic remarks conclude each chapter.

.
Price: $78.00 [Notify me when price goes down.]

The greatest need of anyone with cancer is to understand the disease -- its diagnosis, treatment options, and the often devastating experience of having cancer. In Understanding Cancer, Dr. C. Norman Coleman explains how to gather information about treatments and how to interpret that information to make decisions. He helps the person with cancer prepare for visits to doctors and the hospital and to make those visits as productive as possible. He distills the often complex medical terms and concepts underlying the statistics and percentages used to characterize medical conditions. With clear, in-depth discussions of pretreatment staging of disease, the biology of cancer, how successful treatment is defined, and how best to manage one's time, Understanding Cancer helps people with cancer and their families become active participants in the decision-making process.

In the second edition of this highly respected guide, Dr. Coleman describes new treatments that target specific types of cancer as well as treatments that are designed for a particular individual. He discusses the era of molecular medicine, including biomarkers, novel imaging, molecular signatures and profiling, and molecular-targeted therapy. Many of these therapies are currently only available through a clinical trial, so Dr. Coleman includes a detailed discussion of what is involved in participating in research trials.

Compassionate, accessible, and informative, Understanding Cancer will increase the reader's knowledge of medical concepts and terms so the person with cancer, the family, and the health care team can work together efficiently -- and effectively.

.
Price: $9.03 [Notify me when price goes down.]

.
Price: $260.00 [Notify me when price goes down.]

.
Price: $10.39 [Notify me when price goes down.]

Predicting survival and other outcomes is increasingly being recognized as an important skill for palliative care doctors and nurses, oncologists, and other healthcare professionals who treat patients with advanced cancer. Accurate prognosis is essential if we are to offer quality of care and 'a good death', as well as to aid decision-making. There is much prognostic information available that is scattered throughout the palliative care and oncological literature but this is the first time it has been gathered systematically in one place.
Glare and Christakis, leaders in the field of prognosis, bring together a team of international contributors from across the fields of palliative care and oncology. This comprehensive but practical guide begins with the principles of prognostication, including formulating the prediction and then communicating it. Topics such as statistical issues, evidence-based medicine, and the ethics of prognostication are also covered. The second section addresses prognostication in 15 specific cancer sites once they have reached the advanced stage, following a standard template for consistency and easy access to the key information. The third section deals with prognostication in patients with a variety of common clinical conditions at the end of life, such as bowel obstruction, hypercalcaemia, and brain metastases. In addition, survival curves are provided within each chapter, palliative care conditions are examined for the first time, and a summary table of long and short term prognosis ensures this book remains practical..
Price: $68.65 [Notify me when price goes down.]

This user-friendly guide offers you practical, direct answers for the difficult and little-taught questions that arise when providing care for the dying.
Features:
* Perspectives of patients, families, and other health care professionals, as well as physicians
* Solution-oriented coverage on preparing patients, managing symptoms, and handling legal/ethical issues near the end of life.
Price: $31.00 [Notify me when price goes down.]

Computed tomography of the heart and cardiovascular system continues to show an impressive and tremendously successful development. Technical improvements translate into new applications and enhanced diagnostic accuracy and the new diagnostic opportunities may potentially be beneficial for many individuals with known or suspected cardiovascular disease. In order to assure that the potential of cardiovascular CT will optimally be used for patient care, a continued, strong joint effort concerning education and training, further research, and advocacy will be necessary. The combined knowledge, experience, and input of all clinicians and researchers in the field will best serve that purpose. Cardiovascular Computed Tomography is the first textbook to cover the heart, cardiovascular, and peripheral vascular systems and will provide the reader with the necessary background information to perform cardiac CT on symptomatic patients and asymptomatic individuals for the accurate assessment of underlying disease.
Price: $253.64 [Notify me when price goes down.]

Circulating Tumor Markers of the New Millennium introduces new tumor markers, including cytokines, growth factors, oncoproteins, and mutated suppressor proteins involved in the signal transduction pathway, the cell cycle, and apoptosis. The book also reviews other new tumor markers - angiogenic factors, adhesion molecules, and molecules that are associated with certain types and properties of tumor cells - and describes ELISAs developed for most of them. These new tumor markers differ from currently used tumor markers in that they have the potential for target identification to facilitate more effective target therapy. They might also be used to detect tumors at early or benign stages and to predict prognosis, assisting in the design of therapeutic strategy. This book was written to introduce investigators to the new tumor markers and to encourage investigators to further investigate the clinical applications of these markers..
Price: $37.00 [Notify me when price goes down.]